Tagged With Psychedelics

An investing gold rush is coming for psychedelics. One line from a neuroscientist on their life-changing power explains why.

Mike Tyson smoked a drug derived from toad venom. Here’s what to know about the psychedelic that he says makes you feel like 'you die and you’re reborn.'

A major San Francisco Bay Area city just decriminalized magic mushrooms and ayahuasca

Denver just became the first city in the US to decriminalize magic mushrooms. Here's what they do to your body and mind.

Denver votes to decriminalize 'magic' mushrooms. Here's what that means.

Dispensed: Tim Ferriss is backing psychedelic research, how to change your business model as told by pitch decks, and how much money healthcare CEOs make

Tim Ferriss just helped launch the world's first research center dedicated to turning psychedelics into medicines

A study on psychedelic microdosing in rats revealed promising results for anxiety and depression

Denver could soon become the first US city to decriminalize ‘magic’ mushrooms

Researchers think magic mushrooms could have the potential to treat depression

A top psychedelic scientist says 'the climate's looking good' for magic mushrooms and MDMA to turn into medicines at a gathering of the world's billionaires

10 potential risks of taking 'magic' mushrooms

Denver could become the first US city to decriminalize psychedelic mushrooms

A fresh crop of promising drugs is poised to change the way depression is treated for the first time in decades. Here are the ones to watch in 2019.

Oregon is closer than ever to becoming the first state to legalise 'magic' mushrooms

Evidence is mounting that psychedelic drugs can help treat diseases. Here are the most promising uses.

A team of Johns Hopkins researchers is calling for magic mushrooms to be made legally available as medicine

What ayahuasca — Silicon Valley's latest drug of choice — does to your brain and body

A new biotech company has raised $25 million to help unleash a 'virgin market' of psychedelic research

A new biotech company has raised $25 million to help unleash a 'virgin market' of psychedelic research